Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6043241 | 1.00 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL31180746 | 1.00 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL7158785 | 1.00 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL2263207 | 1.00 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL31180745 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL29710695 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL16678151 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL223632 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL6831561 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 | |
| SCHEMBL7080802 | 0.84 | EPHX2 (0.44) | EPHX2MAPTMAPK1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | claimed |
| US-20240215608-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2024-07-04 | — | — | US | claimed |
| EP-4319559-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | Eastman Chemical Company (US) | 2024-02-14 | — | — | EP | claimed |
| US-11760750-B1 | Process for preparing levoketoconazole | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-09-19 | — | — | US | claimed |
| WO-2022217031-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | WO | claimed |
| EP-4040979-A1 | ANTIMICROBIAL COMPOSITION FOR ANIMAL FEED | Taminco BV (BE) | 2022-08-17 | — | — | EP | claimed |
| CN-111825670-A | Tetrahydrocarboline derivative, preparation method thereof and application thereof in preparing antihypertensive drug | 复旦大学 | 2020-10-27 | — | — | CN | claimed |
| EP-0810861-B1 | SUKSDORFIN ANALOGS, COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THEREOF | UNIV NORTH CAROLINA (US) | 2002-06-05 | — | — | EP | claimed |
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | disclosed |
| WO-2026047069-A1 | SYNTHESIS AND USE OF NOVEL DRIMANE SESQUITERPENOIDS OF KHAMKHAINE TYPE FROM THAI BASIDIOMYCOTA | OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG KÖRPERSCHAFT DES ÖFFENTLICHEN RECHTS (DE) | 2026-03-05 | — | — | WO | disclosed |
| EP-3443338-B1 | METHODS FOR DETECTION OF SAMPLE ENANTIOMERS USING DIFFERENTIAL MOBILITY SPECTROMETRY | DH TECHNOLOGIES DEV PTE LTD (SG) | 2025-07-09 | — | — | EP | disclosed |
| WO-2025093639-A1 | RESIN COMPOSITION FOR THREE-DIMENSIONAL PRINTING | CUBICURE GMBH (AT) | 2025-05-08 | — | — | WO | disclosed |
| EP-4549150-A1 | RESIN COMPOSITION FOR THREE-DIMENSIONAL PRINTING | Cubicure GmbH (AT) | 2025-05-07 | — | — | EP | disclosed |
| US-20250113843-A1 | CELLULOSIC POLYMER-COATED GRANULES | EASTMAN CHEMICAL COMPANY (US) | 2025-04-10 | — | — | US | disclosed |
| EP-0315886-B1 | Isoquinoline derivatives, their manufacture and use | HOFFMANN LA ROCHE (CH) | 1995-02-15 | — | — | EP | disclosed |
| US-5374727-A | Using rhodium-diphosphine complex as hydrogenation catalyst | HOFFMANN-LA ROCHE INC. (US) | 1994-12-20 | — | — | US | disclosed |
| EP-0253503-B1 | SUBSTITUTED ANILIDES HAVING ANTIANDROGENIC PROPERTIES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-12-11 | — | — | EP | disclosed |
| US-4857648-A | Isoquinoline derivatives | HOFFMANN-LA ROCHE INC. (US) | 1989-08-15 | — | — | US | disclosed |
| EP-0315886-A2 | Isoquinoline derivatives, their manufacture and use | F. HOFFMANN-LA ROCHE AG (CH) | 1989-05-17 | — | — | EP | disclosed |
| EP-0253503-A2 | Substituted anilides having antiandrogenic properties | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1988-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | FABP2, FABP1, VIP | EPHX2 3091/4885MAPT 4447/4885MAPK1 1182/4885 |
| US-11760750-B1 | Process for preparing levoketoconazole | KHK, KYAT3, PLK3 | EPHX2 3473/4885MAPT 1668/4885MAPK1 1537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.